Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients

Journal of Thoracic and Cardiovascular Surgery

Volumn 117, Issue 1, 1999, Pages 54-65

  Sugarbaker, D J ^a   Flores, R M ^a   Jaklitsch, M T ^a   Richards, W G ^a   Strauss, G M ^a   Corson, J M ^a   DeCamp M M , Jr ^a   Swanson, S J ^a   Bueno, R ^a   Lukanich, J M ^a   Baldini, E H ^a   Mentzer, S J ^a   Kaiser, L R ^a   Patterson, G A ^a   Faber, L P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0032952875     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(99)70469-1     Document Type: Article

References (43)

1. R Spirtas GW Beebe RR Connelly WE Wright JM Peters RP Sherwin Recent trends in mesothelioma incidence in the United States Am J Ind Med 9 1986 397 407
2. RR Connelly R Spirtas MH Myers CL Percy JF Fraumeni Jr Demographic patterns for mesothelioma in the United States J Natl Cancer Inst 78 1987 1053 1060
3. PE Enterline VL Henderson Geographic patterns of pleural mesothelioma deaths in the United States, 1968-81 J Natl Cancer Inst 79 1987 31 37
4. AP Chahinian RM Ambinder EM Mandel JF Holland Evaluation of 63 patients with diffuse malignant mesothelioma [abstract] Proc Am Soc Clin Oncol 21 1980 360
5. MR Law ME Hodson M Turner-Warwick Malignant mesothelioma of the pleura: clinical aspects and symptomatic treatment [abstract] Eur J Respir Dis 65 1984 162 168
6. P Ruffie R Feld S Minkin Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients J Clin Oncol 7 1989 1157 1168
7. KH Antman Clinical presentation and natural history of benign and malignant mesothelioma Semin Oncol 8 1981 313 320
8. EH Baldini A Recht GM Strauss MM DeCamp Jr SJ Swanson MJ Liptay Patterns of failure after trimodality therapy for malignant pleural mesothelioma Ann Thorac Surg 63 1997 334 338
9. EG Butchart T Ashcroft WC Barnsley MP Holden Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients Thorax 31 1976 15 24
10. K Antman HI Pass A Recht Benign and malignant mesothelioma 3rd ed VT DeVita Jr S Hellman SA Rosenberg Cancer: principles and practice of oncology 1989 JB Lippincott Philadelphia 1399 1414
11. KH Antman HI Pass T DeLaney FP Li J Corson Benign and malignant mesothelioma 4th ed VT DeVita Jr S Hellman SA Rosenberg Cancer: principles and practice of oncology 1993 JB Lippincott Philadelphia 1489 1508
12. DJ Sugarbaker SJ Mentzer M DeCamp TJ Lynch Jr GM Strauss Extrapleural pneumonectomy in the setting of a multimodality approach to malignant mesothelioma Chest 103 suppl 1993 377S 381S
13. DJ Sugarbaker JP Garcia WG Richards DH Harpole Jr HE Baldini MM DeCamp Jr Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: results in 120 consecutive patients Ann Surg 224 1996 288 294 discussion
14. DJ Sugarbaker GM Strauss TJ Lynch W Richards SJ Mentzer TH Lee Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma J Clin Oncol 11 1993 1172 1178
15. DJ Sugarbaker SJ Mentzer G Strauss Extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma Ann Thorac Surg 54 1992 941 946
16. VW Rusch A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group [see comments] Chest 108 1995 1122 1128
17. M Markman D Kelsen Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma J Cancer Res Clin Oncol 118 1992 547 550
18. A Krarup-Hansen HH Hansen Chemotherapy in malignant mesothelioma: a review [abstract] Cancer Chemother Pharmacol 28 1991 319 330
19. NJ Vogelzang J Herndon GH Clamon AM Mauer MR Cooper MR Green Paclitaxel (Taxol) for malignant mesothelioma: a phase II study of the Cancer and Leukemia Group B (CALGB 9234) [abstract] Prog Proc Am Soc Clin Oncol 13 405 1994 1382
20. L Herscher S Hahn H Pass B Temeck B Goldspiel J Cook A phase I study of paclitaxel as a radiation sensitizer for the treatment of non-small cell lung cancer and mesothelioma [abstract] Prog Proc Am Soc Clin Oncol 14 1995 A1530
21. AW Tolcher KA Gelmon Interim results of a phase I/II study of biweekly paclitaxel and cisplatin in patients with metastatic breast cancer Semin Oncol 22 4 Suppl 8 1995 28 32
22. KA Gelmon Biweekly paclitaxel (Taxol) and cisplatin in breast and ovarian cancer Semin Oncol 21 5 Suppl 8 1994 24 28
23. HG Meerpohl A duBois H Kuhnle HJ Luck R Kreienberg V Mobus Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer Semin Oncol 22 6 Suppl 15 1995 712
24. G Blois Pilot study with fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancer Semin Oncol 22 6 suppl 14 1995 32 34
25. L Belli T LeChevalier M Gottfried D Adams P Ruffie A LeCesne Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results Semin Oncol 22 6 Suppl 15 1995 29 33
26. FA Greco SL Stroup JD Hainsworth Paclitaxel by 1-hour infusion in combination chemotherapy of stage III non-small cell lung cancer Semin Oncol 22 4 Suppl 9 1995 75 77
27. FM Muggia D Vafai R Natale V Israel S Zaretsky AM McRae Paclitaxel 3-hour infusion given alone and combined with preliminary results of dose-escalation trials Semin Oncol 22 4 Suppl 9 1995 63 66
28. GM Strauss TJ Lynch AD Elias C Jacobs DJ Kwiatkowski LN Shulman A phase I study of ifosfamide/carboplatin/ etoposide/paclitaxel in advanced lung cancer Semin Oncol 22 4 Suppl 9 1995 70 74
29. PA Bunn Jr K Kelly A phase I study of carboplatin and paclitaxel in non-small cell lung cancer: a University of Colorado Cancer Center study Semin Oncol 22 4 Suppl 9 1995 26
30. SJ Antonia H Wagner C Williams M Alberts D Hubbell L Robinson Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage IIIA/B non-small cell carcinoma of the lung Semin Oncol 22 4 Suppl 9 1995 34 37
31. CJ Langer JC Leighton RL Comis PJ O'Dwyer CA McAleer CA Bonjo Paclitaxel by 24- or 1-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience Semin Oncol 22 4 Suppl 9 1995 18 29
32. AP Chahinian JP Mandeli H Gluck H Naim AS Teirstein JF Holland Effectiveness of cisplatin, paclitaxel, and suramin against human malignant mesothelioma xenografts in athymic nude mice J Surg Oncol 67 1998 104 111
33. CT Griffiths RH Grogan TC Hall Advanced ovarian cancer: primary treatment with surgery, radiotherapy, and chemotherapy Cancer 29 1972 1 7
34. PH Sugarbaker Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology PH Sugarbaker Peritoneal carcinomatosis: principles of management 1996 Kluwer Academic Publishers Boston 79 100
35. HI Pass TF DeLaney Z Tochner PE Smith BK Temeck HW Pogrebniak Intrapleural photodynamic therapy: results of a Phase I trial Ann Surg Oncol 1 1994 28 37
36. HI Pass BK Temeck K Kranda G Thomas A Russo P Smith Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma Ann Surg Oncol 4 1997 628 633
37. V Rusch L Saltz E Venkatraman R Ginsberg P McCormack M Burt A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma J Clin Oncol 12 1994 1156 1163
38. VW Rusch Pleurectomy/decortication in the setting of multimodality treatment for diffuse malignant pleural mesothelioma Semin Thorac Cardiovasc Surg 9 1997 367 372
39. G Los MJ vanVugt HM Pinedo Potentiation of Ip chemotherapy by abdominal hyperthermia in rats [abstract] Proc Ann Meet Am Assoc Cancer Res 33 1992 A2980
40. G Los EM Verdegaal PH Mutsaers JG McVie Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy Cancer Chemother Pharmacol 28 1991 159 165
41. G Los JG McVie Experimental and clinical status of intraperitoneal chemotherapy Eur J Cancer 26 1990 762 775
42. P Jacquet AD Stephens AM Averbach D Chang SE Ettinghausen RR Dalton Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy Cancer 77 1996 2622 2629
43. K Kodama O Doi M Tatsuta K Kuriyama R Tateishi Development of postoperative intrathoracic chemo-thermotherapy for lung cancer with objective of improving local cure Cancer 64 1989 1422 1428